All In MedTech

Device Trial Radar · NCT06724146

Combined Treatment Sofwave and Pure Impact to Strength and Tone Muscles and Improve Lax Skin Appearance

Safety and Efficacy of Upper Arm Combined Treatment Sofwave and Pure Impact to Strength and Tone Muscles and Improve Lax Skin Appearance

Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

70

Actual

Start

Aug 5, 2024

Primary completion

Oct 1, 2026

Study completion Nov 1, 2026

Sponsor

Lead sponsor
Sofwave Medical LTDNot on our public-company list
Sponsor type
Industry
First posted
Dec 9, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 25 years, up to 70 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Open-label, non-randomized, prospective, multi-center, self-controlled clinical study.

Conditions

  • Skin Lax and Muscle Strength

Interventions

  • Sofwave and Pure ImpactDevice

    The Sofwave System, comprised of an applicator and a console, generates high intensity, non-focused ultrasonic energy which can be delivered percutaneously to tissues. Pure Impact is an EMS module. This module is wirelessly connected to and controlled by the SofWave console. It functions independently from the existing ultrasound module. Pure Impact generates electrical impulses, which are delivered through electrodes on the skin in direct proximity to the muscles to be stimulated.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Improvement in the appearance of lax skinTime frame: 3 months post treatment follow-up visit

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Tennessee Clinical Research Center

    Nashville, Tennessee

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.